Share
|
Copy Link
https://eyewire.news/tv/eyewire-tv-february-16th-2022
https://eyewire.news/tv/genentech-provides-2-year-phase-3-data-for-vabysmo-and-susvimo
https://eyewire.news/tv/novartis-presents-new-data-from-three-phase-3-trials-of-beovu-in-dme
https://eyewire.news/tv/regeneron-presents-phase-2-results-for-high-dose-aflibercept-in-wet-amd